Last reviewed · How we verify
XinNaoJing injection — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
XinNaoJing injection (XinNaoJing injection) — The Second Affiliated Hospital of Kunming Medical University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| XinNaoJing injection TARGET | XinNaoJing injection | The Second Affiliated Hospital of Kunming Medical University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- XinNaoJing injection CI watch — RSS
- XinNaoJing injection CI watch — Atom
- XinNaoJing injection CI watch — JSON
- XinNaoJing injection alone — RSS
Cite this brief
Drug Landscape (2026). XinNaoJing injection — Competitive Intelligence Brief. https://druglandscape.com/ci/xinnaojing-injection. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab